1. Ramos LJ, Rodriguez LMI, Angiler LP, Aguirre RJ, Cassinello GE. A study of drug-resistant epilepsy testing the new ILAE criteria. Seizure. 2012;266–72.
2. Glauser T, Ben ME, Bourgeois B, et al. Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia. 2013;1–13.
3. Kwan P, Arzimanoglou A, Berg AT, et al. Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia. 2010;51:1069–77.
4. Akhondian J, Heydarian F, Jafari SA. Predictive factors of pediatric intractable seizures. Arch Iranian Med. 2006;9:236–9.
5. Shahar E, Genizi J. Predictive factors of seizure control in childhood onset epilepsy. J Pediatr Neurosci. 2008;3:117–20.
6. Laupacis A, Sekar N, Stiell IG. Clinical prediction rule. A review and suggested modifications of methodological standard. JAMA. 1997;277:488–94.
7. Wasson JH, Sox HC, Neff RK, Goldman L. Clinical prediction rules. Application and methodological standards. N Eng J Med. 1985;313:793–9.
8. Adams ST, Leveson SH. Clinical prediction rules. BMJ. 2012;344:1–17.
9. Fisher RS, Acevedo C, Arzimanoglou A, et al. A practical clinical definition of epilepsy. Epilepsia. 2014;55:475–82.
10. French JA. Refractory epilepsy: clinical overview. Epilepsia. 2007;48:Suppl 1. 3–7.
11. Ramos-Lizana J, Aguilera-López P, Aguirre-Rodríguez J, Cassinello-García E. Response to sequential treatment schedules in children epilepsy: risk for development of refractory epilepsy. Seizure. 2009;18:620–4.
12. Berg AT, Vickrey BG, Testa FM, et al. How long does it take for epilepsy to become intractable? A prospective investigation. Ann Neurol. 2006;60:73–9.
13. McGinn TG, Guyatt GH, Wyer PC. Users’ guides to the medical literature: XXII: how to use articles about clinical decision rules. Evidence-Based Medicine Working Group. JAMA. 2000;284:79–84.
14. Plüddemann A, Emma WE, Clare BC, et al. Clinical prediction rules in practice: review of clinical guidelines and survey of GPs. Br J Gen Pract. 2014;64:e233–42.
15. Berg AT, Shinnar S, Levy SR. Early development of intractable epilepsy in children: a prospective study. Neurology. 2001;56:1430–1.
16. Cockerell OC, Johnson AL, Sander JW. Prognosis of epilepsy: a review and further analysis of the first nine years of the British National General Practice Study of Epilepsy, a prospective population based study. Epilepsia. 1997;38:33–46.
17. Shafer SQ, Jauser WA, Annegers JF. EEG and other early predictors of epilepsy remission: a community study. Epilepsia. 1998;29:590–600.
18. Grobman WA, Siamilio DM. Methods of clinical prediction. Am J Obste Gynecol. 2006;194:888–94.
19. Bouma PA, Bovenkerk AC, Westendorp RG, Brouwer OF. The course of benign partial epilepsy of childhood with centrotemporal spikes: a meta-analysis. Neurology. 1997;48:430–7.
20. Gelisse P, Genton P, Thomas P, Rey M, Samuelian JC, Dravet C. Clinical factors of drug resistance in juvenile myoclonic epilepsy. J Neurosurg Psychiatry. 2001;70:240–3.